SCHEMBL29960682

SCHEMBL29960682

CCOC(=O)C=Cc1ccccc1NS(C)(=O)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.50
TSHR P16473 2/20 0.50
KDM4E B2RXH2 1/20 0.50
MAPT P10636 3/20 0.49
LMNA P02545 2/20 0.49
MDM2 Q00987 1/20 0.49
AKT1 P31749 1/20 0.45
CNKSR1 Q969H4 1/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
HPGD P15428 2/20 0.44
ALDH1A1 P00352 1/20 0.44
MAPK1 P28482 1/20 0.44
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
CYP3A4 P08684 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15888927 0.90 KEAP1 (0.47) HSD17B10TSHRKDM4EMAPTLMNA
SCHEMBL10783189 0.81 CA12 (0.59) KDM4EMAPTLMNAMDM2CA12
SCHEMBL8740665 0.81 MAPT (0.55) TSHRKDM4EMAPTLMNAMDM2
SCHEMBL4796094 0.81 MAPT (0.51) KDM4EMAPTLMNAMDM2CA12
SCHEMBL1405343 0.80 LMNA (0.53) HSD17B10TSHRKDM4EMAPTLMNA
SCHEMBL1405342 0.80 LMNA (0.53) HSD17B10TSHRKDM4EMAPTLMNA
SCHEMBL11054639 0.79 CA12 (0.57) KDM4EMAPTLMNAMDM2CA12
SCHEMBL28970711 0.77 MAPT (0.51) KDM4EMAPTLMNAMDM2CA12
SCHEMBL1897277 0.76 CA12 (0.54) KDM4EMAPTLMNAMDM2CA12
SCHEMBL1897276 0.76 CA12 (0.54) KDM4EMAPTLMNAMDM2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022204150-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS BLUE OAK PHARMACEUTICALS, INC. (US) 2022-09-29 WO disclosed